Clinical Trial Update: Actifuse ABX Versus INFUSE in Posterolateral Instrumented Lumbar Fusion (PLIF) With Interbody Fusion [NA]

View source ↗

Summary

A completed clinical trial comparing Actifuse ABX to INFUSE in posterolateral instrumented lumbar fusion with interbody fusion for degenerative disc disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Disc Disease

Drugs mentioned

• Actifuse ABX (calcium phosphate bone graft substitute with antibiotics)
• Infuse (recombinant human bone morphogenetic protein-2)

Snippet

Sponsor: Baxter Healthcare Corporation | Conditions: Degenerative Disc Disease | NA | Status: COMPLETED